Triple-negative breast cancer (TNBC) represents a highly aggressive and complex subtype of breast cancer characterized by the absence of three important receptors: the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast cancer.